2024 |
Qiagen NV
|
Managing Director and Chief Executive Officer |
1.5 M |
-29.2 % |
2023 |
Qiagen NV
|
- |
2.1 M |
-0.5 % |
2022 |
Qiagen NV
|
Managing Director and Chief Executive Officer |
2.1 M |
-4.4 % |
2021 |
Qiagen NV
|
- |
2.2 M |
-13.0 % |
2021 |
Qiagen NV
|
Managing Director and Chief Executive Officer |
2.2 M |
-13.0 % |
2020 |
Qiagen NV
|
- |
2.6 M |
115.4 % |
2020 |
Qiagen NV
|
- |
2.6 M |
115.4 % |
2020 |
Qiagen NV
|
Managing Director and Chief Executive Officer |
2.6 M |
115.4 % |
2019 |
Qiagen NV
|
- |
1.2 M |
- |
2019 |
Qiagen NV
|
- |
1.2 M |
- |
2019 |
Qiagen NV
|
Interim Chief Executive Officer and Senior Vice President, Head of Molecular Diagnostics Business Area |
1.2 M |
- |